Hughes, B.; Grob, J.-J. .; Bowyer, S.; Day, F. .; Ladwa, R.; Stein, B. .; Muñoz-Couselo, E.; Basset-Seguin, N.; Guminski, A. .; Mortier, L. .; Hauschild, A. .; Migden, M. .; Schmults, C. .; Yoo, S.-Y.; Booth, J. .; Seebach, F. .; Lowy, I. .; Fury, M.; Rischin, D. . Phase 2 Confirmatory Study of Cemiplimab (350 Mg IV Q3W) in Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Study 1540 Group 6. J of Skin 2023, 7, s175.